Vaxcell-Bio Therapeutics (323990) Price & Analysis

― Followers

323990 Stock Chart & Stats

₩3955.00

₩340.00(9.41%)

Jul 31, 2026

―

Day’s Range― - ―

52-Week Range₩3,350.00 - ₩11,520.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)216.68K

Market Cap

₩91.65B

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta0.24

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding23,257,345

10 Day Avg. Volume92,701

30 Day Avg. Volume216,684

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

323990 FAQ

What was Vaxcell-Bio Therapeutics’s price range in the past 12 months?

Vaxcell-Bio Therapeutics lowest stock price was ₩3350.00 and its highest was ₩11520.00 in the past 12 months.

What is Vaxcell-Bio Therapeutics’s market cap?

Vaxcell-Bio Therapeutics’s market cap is ₩91.65B.

When is Vaxcell-Bio Therapeutics’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Vaxcell-Bio Therapeutics’s earnings last quarter?

Vaxcell-Bio Therapeutics released its earnings results on May 15, 2026. The company reported -₩171.275 earnings per share for the quarter, missing the consensus estimate of N/A by -₩171.275.

Is Vaxcell-Bio Therapeutics overvalued?

According to Wall Street analysts Vaxcell-Bio Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Vaxcell-Bio Therapeutics pay dividends?

Vaxcell-Bio Therapeutics does not currently pay dividends.

What is Vaxcell-Bio Therapeutics’s EPS estimate?

Vaxcell-Bio Therapeutics’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Vaxcell-Bio Therapeutics have?

Vaxcell-Bio Therapeutics has 23,257,345 shares outstanding.

What happened to Vaxcell-Bio Therapeutics’s price movement after its last earnings report?

Vaxcell-Bio Therapeutics reported an EPS of -₩171.275 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.432%.

Which hedge fund is a major shareholder of Vaxcell-Bio Therapeutics?

Currently, no hedge funds are holding shares in KR:323990

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology